|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1992-12-17
|
|
pubmed:abstractText |
A study of 90 patients with endoscopically proved duodenal ulcer revealed that dalargin and trichopol+dalargin treatment resulted in early scarring of the ulcer and control of gastroesophageal and duodenogastric reflux in the majority of patients. Gastroduodenitis symptoms were not eliminated in a half of all patients. It was shown that persistent manifestations of gastroduodenitis remained in patients with a pronounced pyloric helicobacteriosis and a high titer of antibodies to cells of the gastric mucosa.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1019-5297
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
35-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:1441328-Adolescent,
pubmed-meshheading:1441328-Adult,
pubmed-meshheading:1441328-Anti-Bacterial Agents,
pubmed-meshheading:1441328-Anti-Ulcer Agents,
pubmed-meshheading:1441328-Drug Evaluation,
pubmed-meshheading:1441328-Drug Therapy, Combination,
pubmed-meshheading:1441328-Duodenal Ulcer,
pubmed-meshheading:1441328-Enkephalin, Leucine-2-Alanine,
pubmed-meshheading:1441328-Female,
pubmed-meshheading:1441328-Helicobacter Infections,
pubmed-meshheading:1441328-Helicobacter pylori,
pubmed-meshheading:1441328-Humans,
pubmed-meshheading:1441328-Male,
pubmed-meshheading:1441328-Middle Aged,
pubmed-meshheading:1441328-Organometallic Compounds
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
[The efficacy of treating peptic ulcer patients with trichopol and dalargin].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
